Literature DB >> 17976311

The current immune function of hepatic dendritic cells.

Willy Hsu1, Shang-An Shu, Eric Gershwin, Zhe-Xiong Lian.   

Abstract

While only a small percentage of the liver as dendritic cells, they play a major role in the regulation of liver immunity. Four major types of dendritic cell subsets include myeloid CD8alpha(-)B220(-), lymphoid CD8alpha(+)B220(-), plasmacytoid CD8alpha(-)B220(+), and natural killer dendritic cell with CD8alpha(-)B220(-)NK1.1(+) phenotype. Although these subsets have slightly different characteristics, they are all poor naïve T cell stimulators. In exchange for their reduced capacity for allostimulation, hepatic DCs are equipped with an enhanced ability to secrete cytokines in response to TLR stimulation. In addition, they have increased level of phagocytosis. Both of these traits suggest hepatic DC as part of the innate immune system. With such a high rate of exposure to the dietary and commensal antigens, it is important for the hepatic DCs to have an enhanced innate response while maintaining a tolerogenic state to avoid chronic inflammation. Only upon secondary infectivity does the hepatic DC activate memory T cells for rapid eradication of recurring pathogen. On the other hand, overly tolerogenic characteristics of hepatic DC may be responsible for the increase prevalence of autoimmunity or liver malignancies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17976311

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  20 in total

Review 1.  Immune Cell Trafficking to the Liver.

Authors:  Sulemon Chaudhry; Jean Emond; Adam Griesemer
Journal:  Transplantation       Date:  2019-07       Impact factor: 4.939

Review 2.  Immunomodulatory effects of transforming growth factor-β in the liver.

Authors:  Hans-Theo Schon; Ralf Weiskirchen
Journal:  Hepatobiliary Surg Nutr       Date:  2014-12       Impact factor: 7.293

3.  Critical roles of conventional dendritic cells in promoting T cell-dependent hepatitis through regulating natural killer T cells.

Authors:  J Wang; X Cao; J Zhao; H Zhao; J Wei; Q Li; X Qi; Z Yang; L Wang; H Zhang; L Bai; Z Wu; L Zhao; Z Hong; Z Yin
Journal:  Clin Exp Immunol       Date:  2017-01-05       Impact factor: 4.330

Review 4.  Innate immunity in alcoholic liver disease.

Authors:  Bin Gao; Ekihiro Seki; David A Brenner; Scott Friedman; Jessica I Cohen; Laura Nagy; Gyongyi Szabo; Samir Zakhari
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-01-20       Impact factor: 4.052

Review 5.  Role of innate immunity in the development of hepatocellular carcinoma.

Authors:  Rajagopal N Aravalli
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

6.  Immunostimulatory properties of dendritic cells after Leishmania donovani infection using an in vitro model of liver microenvironment.

Authors:  Ludovic Donaghy; Florian Cabillic; Anne Corlu; Octavie Rostan; Olivier Toutirais; Christiane Guguen-Guillouzo; Claude Guiguen; Jean-Pierre Gangneux
Journal:  PLoS Negl Trop Dis       Date:  2010-06-08

Review 7.  Microanatomy of the liver immune system.

Authors:  Eszter Nemeth; Alan W Baird; Cliona O'Farrelly
Journal:  Semin Immunopathol       Date:  2009-07-29       Impact factor: 9.623

8.  Zinc finger proteins designed to specifically target duck hepatitis B virus covalently closed circular DNA inhibit viral transcription in tissue culture.

Authors:  Kimberley A Zimmerman; Karl P Fischer; Michael A Joyce; D Lorne J Tyrrell
Journal:  J Virol       Date:  2008-06-04       Impact factor: 5.103

9.  NOD2 ligation subverts IFN-alpha production by liver plasmacytoid dendritic cells and inhibits their T cell allostimulatory activity via B7-H1 up-regulation.

Authors:  Antonino Castellaneta; Tina L Sumpter; Lieping Chen; Daisuke Tokita; Angus W Thomson
Journal:  J Immunol       Date:  2009-11-04       Impact factor: 5.422

10.  Immune tolerance in liver disease.

Authors:  Ian N Crispe
Journal:  Hepatology       Date:  2014-09-26       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.